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Abstract
Background: The American Shoulder and Elbow Surgeons (ASES) annual scientific meetings are premier forums
whereby orthopaedic surgeons are informed of the latest research advances in shoulder and elbow surgery. The
purpose of the present study was to assess the Level of evidence (LOE) in the clinical papers presented at both the
open and closed ASES annual scientific meetings from 2005 to 2014. Secondarily, the study evaluated whether
there were any changes in the distribution of LOE over this period of time.
Methods: Two reviewers independently evaluated the abstracts of 532 paper presentations at either the open or
closed ASES annual meetings. The independent reviewers first screened the abstracts for clinical evidence and
excluded cadaveric, biomechanical, technique, and review studies. The included abstracts were then independently
graded for methodological quality using LOE from Level I (highest quality) to IV (lowest quality) based on the
classification system created by The American Academy of Orthopaedic Surgeons (AAOS).
Results: Overall, 421 presentations were included and graded for LOE. In general, 17% of the presentations were
graded level I; 15% level II; 25% level III; and 43% assigned a LOE of IV. Chi-square analysis demonstrated a
statistically significant improvement in the LOE of presentations at the open and closed ASES meetings combined
(p = 0.028) between the years 2005 and 2014. In particular, the proportion of presentations graded as level IV
significantly decreased over this period (p = <0.001).
Conclusions: While most presentations at the ASES annual scientific meetings were of lower LOEs the percentage
of level I evidence is greater than that reported at other Orthopaedic meetings. There has been a significant
improvement in the LOE of clinical research at open and closed ASES meetings from 2005 to 2014. Specifically, the
proportion of level IV studies have dramatically decreased over time.
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Background
The American Shoulder and Elbow Surgeons (ASES) is a
leading subspecialty association comprised of shoulder
and elbow surgeons and focuses on promoting the highest
quality of care available. The ASES holds two meetings
each year (closed for members, and open for both mem-
bers and non-members). These meetings act as important
sources of information for all Orthopaedic surgeons and
are particularly influential on those who are focusing on
the shoulder or elbow joints. Research findings from pre-
sentations at these meetings may have a direct impact on
clinical decision-making or even on health policies. Thus,
it is critical that the research presented at these meetings
is of quality that is near the top of the hierarchy of evi-
dence. Sackett and colleagues introduced the important
ideas of Evidence-Based Medicine which emphasizes the
importance of research from study designs of high meth-
odological quality in clinical decision making [1, 2]. One
method of classifying the methodological quality of a
study is by using Level of evidence (LOE). Such LOEs
(level I to level IV) are assigned to a study based on the
methodological design of the study with high quality ran-
domized controlled trials (RCT) grades as level I and case
report or case series graded as level IV. It is thought that
studies with higher quality methodology can be applied
more reliably to clinical practice. A standard approach for
grading Orthopaedic research has been created by The
American Academy of Orthopaedic Surgeons (AAOS)
which is an updated version of the system originally
described by The Journal of Bone and Joint Surgery [3].
The quality and type of presentations at scientific
meetings may be effected by different factors. For ex-
ample, the inherent nature of Orthopaedics may inhibit
the production of high quality evidence with rigorous
methodology, particularly when studying new proce-
dures. The incidence and applicability of elbow and
shoulder arthroscopy have increased since the turn of
the millennium and their use has recently expanded
and are now indicated for some fractures as well [4].
Furthermore, under the influence of EBM, many
Orthopaedic journals began introducing LOEs to all
publications between 2003 and 2005. Another import-
ant consideration pertains to the difference between the
open and closed meetings. The open meetings typically
contain presentations of more common and studied
topics, and therefore often have immediate clinical im-
plication. On the other hand, newer topics that are in
the critical review process are often presented at the
closed meetings. The purpose of the present study was
to evaluate the LOE of the papers presented at both the
open and closed ASES annual scientific meeting be-
tween the year 2005 and 2014. Secondarily, this study
assessed whether there were any changes in the distri-
bution of LOE over this period of time.
Methods
Study eligibility
The methodology used to assess the quality of presenta-
tions at ASES meetings in this study are similar to those
used to assess the quality of presentations at the Inter-
national Society for Hip Arthroscopy (ISHA) meeting in
a previous study [5]. The inclusion criteria were clinical
papers presented at the ASES annual open and closed
meeting between 2005 and 2014. Any trial or observa-
tional study with direct communication between human
subjects and an investigator and was considered to be a
clinical study. The exclusion criteria were cadaveric
studies, biomechanical studies, technique presentations,
and expert panel discussions.
Screening and grading
The abstracts for papers presented at several of the open
and closed ASES annual meetings have been electronic-
ally published and made available through The Journal of
Shoulder and Elbow Surgery (JSES). The ASES was con-
tacted to inquire about abstracts that were not pub-
lished. The abstracts of available presentations were
screened independently by two reviewers. The included
abstracts were then graded for LOE (Level I to IV) by
two independent reviewers using the AAOS classifica-
tion scheme [3]. If there were any disagreements, these
were discussed by the two reviewers at the end of the ini-
tial assessment until they reached a consensus. A senior
author was consulted as necessary for disagreements.
Data extraction and statistical analysis
Data that was abstracted from the included presentations
include: study type, sample size, LOE, and study location.
Microsoft Excel 2013 (Microsoft, Redmond, WA) was
used to record extracted data. Kappa (κ) was calculated
for both the screening stage and the presentation evalu-
ation stage to evaluate the inter- reviewer agreement. A
priori categorization of the level of agreement was as fol-
lows: κ of 0.20 or less was considered slight agreement; κ
of 0.21 to 0.60, moderate agreement; and κ of 0.61 or
greater, substantial agreement. For all meetings included
in the analysis, the frequency of each LOE was calculated
by dividing the number by the total number of included
presentations for that meeting. Non-random statistical
changes in the LOE distribution over time were evaluated
using Pearson Chi-square analyses. While these tests do
not tell us about trend, they do provide important infor-
mation regarding the change in LOE over time. A signifi-
cance level of p ≤ 0.05 was used for the general analyses.
However, when all four LOEs were evaluated separately,
this threshold was adjusted to 0.0125 using the conserva-
tive Bonferroni correction for multiple tests. Minitab ®
statistical software version 17 (Minitab Inc., State College,
USA) was used for all statistical calculations.
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Results
Four hundred twenty-one of the 532 presentations avail-
able online between 2005 and 2014 met the inclusion
criteria and were assessed for LOE. There was no data
available on presentations from the open meeting in
2007 and on the closed meeting in 2010, 2011 and 2013,
as the abstracts from these meetings were not published,
and they could not be obtained through contacting the
ASES administrators. The agreement between reviewers
was considered to be substantial for both abstract
screening as well as LOE evaluation with κ (95% confi-
dence intervals [CI]) values of 0.98 (0.93, 1.00) and 0.85
(0.82, 0.88), respectively. In general, 17% (95% CI, 13 to
21%) of the presentations were graded as level I
evidence, 15% (95% CI, 12 to 18%) level II evidence, 25%
(95% CI, 21 to 29%) level III evidence and 43% (95% CI,
38 to 48%) level IV evidence with a mean LOE of III
(2.93) over the 10 years that were analyzed.
The 421 presentations that were evaluated had a mean
sample size of 363 (standard error of the mean [SEM]
172) subjects. Therapeutic studies were the most com-
monly presented study design overall (64%, 95% CI: 59
to 69%), however, there was variation in the proportion
of therapeutic studies for each LOE. For example, only
41% of all level II studies in comparison to 92% of level
IV studies were therapeutic. Prognostic studies were the
next most frequently presented study (28%, 95% CI: 24
to 32%) while diagnostic and economic studies com-
prised only 5% (95% CI, 3 to 7%) and 1% (95% CI 0 to
1%) of all presentations, respectively. There were a total
of 15 different countries recorded as the country of rec-
ord for the primary authors, although only 83 of 421
were from outside of the USA.
Comparing all abstracts presented in the first five years
of our analysis (2005–2009) with abstracts over the last
five years of the analysis (2010–2014) the percentage of
level I (15 to 20%), level II (15 to 17%) and level III (19
to 32%) evidence increased while the percentage of level
IV evidence (51 to 31%) decreased. The percentage of
papers presented over time is displayed in Figs. 1 and 2
for the open and closed meetings respectively.
When comparing the meeting types, the open meeting
had a higher percentage of level I (19% vs. 15%) and a
lower percentage of level IV presentations (41% vs. 46%)
than the closed meeting. The closed meeting had a higher
percentage of level II (17% vs. 14%) and a lower pe-
rcentage of level III presentations (26% vs. 23%). There
was no significant difference between the LOEs presented
at the open meeting in comparison to the closed meeting
(p = 0.805).
Due to the small annual sample size at each meeting
(20–40 presentations), the chi-squared analysis resulted in
few significant changes when comparing meetings indi-
vidually. The overall association between LOE and year
presented for presentations at the open (p = 0.089) and
closed (p = 0.127) meetings alone were not significant.
The open and closed meetings individually showed no
significant changes in level I (p = 0.405, p = 0.499), level II
(p = 0.465, p = 0.342) or level III (p = 0.143, p = 0.170) evi-
dence over the years 2005–2014. While there were no sig-
nificant changes in level IV evidence at the closed meeting
(p = 0.028) there was a significant (p = 0.0120) decrease in
level IV evidence presented at the open meetings between
2005 and 2014.
There was a significant, non-random improvement in
LOE overall for presentations presented at the open
and closed meeting combined (p = 0.028) over the years
2005–2014. Focused analysis of each LOE revealed no
significant changes in level I evidence (p = 0.770), level
II evidence (p = 0.421) or level III evidence (p = 0.046),
but there was a significant decrease in level IV evidence
(p < 0.001).
Fig. 1 The percentage of scientific clinical presentations by LOE and years of presentation for the open ASES meetings
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Discussion
The ASES annual scientific meetings are important
venues that focus on the presentation of high quality
and evidence-based outcome measures for the most im-
portant procedures addressing injuries or disease of the
shoulder and elbow.
Overall, the presentations over the past ten years at
ASES meetings predominantly used lower quality study
designs, with 68% of all presentations graded as either
level III or IV evidence. The most common presenta-
tions were level IV studies, which encompassed 41% of
paper presentations from the open meeting and 46% of
paper presentations from the closed meeting between
2005 and 2014. Level IV studies are mostly case series,
which describe outcomes from a single cohort of pa-
tients without comparison to a control group. The lack
of a control group affords level IV studies with inherent
sources of bias including: measurement bias, selection
bias, and bias from confounding factors that are un-
accounted for. As such, the attendees of these meetings
should avoid using the outcomes generated from such
studies as the sole basis of treatment decisions. While
research of lower methodological quality may not always
have direct clinical relevance, these studies are important
sources of information that can be used to generate hy-
potheses to direct the focus of future studies with im-
proved study designs [6].
Between 2005 and 2014, there was a significant de-
crease in the presentation of level IV evidence in both
the open and closed annual meetings combined and in
the open meeting alone. These changes could indicate
an increased understanding and use of new procedures
concerning the shoulder and elbow. Due to the aging
population, degenerative shoulder problems such as
osteoarthritis and rotator cuff disease are becoming in-
creasingly common [7]. The use of shoulder arthroplasty
has increased substantially since the United States Food
and Drug Administration approved the use of reverse
total arthroplasty in 2003 [8]. This procedure has been a
very important contribution for treatment of conditions
such as rotator cuff insufficiency, arthropathy and some
fractures [7]. The use of elbow arthroscopy was initially
described as unfeasible in 1931, however newer technol-
ogy and a better understanding of the anatomy of the
elbow has since allowed an increase in the prevalence of
arthroscopic elbow surgery [4]. As data is compiled from
early research evaluating these new procedures, the pro-
duction of research with improved study designs be-
comes progressively more feasible. Furthermore, many
Orthopaedic journals including the Journal of Bone and
Joint Surgery, American Journal of Sports Medicine, and
JSES have required and included the LOE as part of the
publication of research manuscripts. Not only do pub-
lished LOE allow clinicians to understand the context
with which to interpret a study, but it also provides
Orthopaedic surgeons a greater awareness of the import-
ance of studies with higher methodological quality or
LOE [9]. Most Orthopaedic journals, including the JSES,
have demonstrated increased production of publications
with level I and II evidence since the introduction of
LOE in these journals [10]. Therefore, we could attribute
the improvement in the methodological quality of
research at ASES meetings to an increased quantity of
research submitted in addition to the influence of EBM,
facilitated partially by the inclusion of LOE in most
Orthopedic journals at the beginning of our study
period.
Although the statistical analysis did not indicate a
significant change in the proportion of level I studies
between 2005 and 2014, the relatively small sample size
of level I evidence may have contributed to the negative
finding. The percentage of level I evidence increased
Fig. 2 The percentage of scientific clinical presentations by LOE and year of presentation for the closed ASES meetings
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from 15% before 2010 to 20% after 2010. Of the 17% of
studies that were classified as level I, 57% were thera-
peutic indicating that 10% of all studies were RCTs. The
percentage of level I evidence at ASES meetings between
2005 and 2014 represents a much higher number than
that presented at the AAOS (7% in 2010) meeting and
even greater than the percentage of level I and II presen-
tations combined at the Pediatric Orthopaedic Society of
North America (POSNA) meetings (14% over 2001,
2002, 2007 and 2008) [11, 12]. The proportion of level I
research is especially impressive considering the recognized
difficulty in performing a randomized study with surgical
interventions. Some key challenges inherent to surgical tri-
als include patients’ reluctance to randomization as well as
the difficulty blinding surgeons to the interventions [13].
These challenges limit the number of RCTs conducted, but
also impact the quality of those produced as Bhandari et al.
reported that the majority of randomized trials published in
The Journal of Bone and Joint Surgery did not report the
use of key methodological features such as proper alloca-
tion concealment, exclusion of patients, and blinded assess-
ment of outcomes [14]. RCTs studying elbow pathology in
particular, are not of the highest quality and have not
shown an improvement in their quality in recent years [15].
On the other hand, McCormick et al. have reported that,
according to the Jadad score, RCTs studying rotator cuff
pathology are of high quality [14, 16]. Although there are
difficulties conducting RCTs in surgery, Farrokhyar et al.
have reported that RCTs for novel surgical interventions
are important and can be produced if the feasibility is prop-
erly assessed initially and close attention is addressed to
specific methodological details [12].
Overall, statistical analyses indicate a significant im-
provement in the LOE of presentations at the open and
closed annual ASES meetings from 2005 to 2014. The
average LOE during the period between 2005 and 2009
was 3.07 and improved to 2.75 in the period between
2010 and 2014. Voleti and colleagues evaluated the
poster and paper presentations at the AAOS meetings
and demonstrated significant improvements in the
average LOE between 2001 (3.46) and 2010 (2.88) [11].
The program committee for ASES meetings diligently
screen submitted abstracts and include only presenta-
tions of the highest quality, however, the quality of ab-
stracts that are being submitted is often the limiting
factor to such selection. Therefore, the changes identi-
fied in the present study are likely indicative of an im-
provement in the methodological quality of the research
being submitted for presentation at these meetings. One
method that can be used to educate the audience as well
as the submitting authors on the importance of high
methodological quality is having authors include the
LOE of their study accompanying the abstract. However,
Shmidt et al. studied presentations for which authors
provided a LOE at AAOS meetings and have reported
that authors tend to rate their own studies with a higher
LOE than an independent reviewer [17]. Therefore, if
LOEs are to be included with meeting presentations, it
may be beneficial to have these verified by an independ-
ent reviewer.
A strength of this study is that it is the first, to the best
knowledge of the authors, to evaluate the methodological
quality of the research presented at the ASES annual
scientific meetings. There was high agreement amongst
the reviewers in terms of the evaluation of LOEs, indicat-
ing that the evidence was categorized consistently. Li-
mitations of this study include the availability of abstracts
(no abstracts from the years 2007, 2010, 2011 and 2013)
and the limited methodological information available
based on the 300 word abstract alone. Missing data may
have affected the statistical tests assessing the methodo-
logical quality over time.
Conclusions
The ASES annual meeting is at the forefront in present-
ing the latest research in the arenas of shoulder and
elbow surgery and therefore the presentations at these
meetings may act as a surrogate marker for the latest re-
search in these fields. While most presentations at the
ASES annual scientific meetings were of lower LOEs the
percentage of level I evidence is greater than that re-
ported at other Orthopaedic meetings. There has been a
significant improvement in the LOE of clinical research
at open and closed ASES meetings from 2005 to 2014.
Specifically, the proportion of level IV studies have dra-
matically decreased over time.
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